ACM
NAUT icon

AH Capital Management’s Nautilus Biotechnolgy NAUT Stock Holding History

AH Capital Management’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.9M Sell
9,063,054
-8,590,863
-49% -$22.7M 0.12% 12
2026
Q1 		$68.5M Hold
17,653,917
– – 5.31% 5
2025
Q4 		$34.4M Hold
17,653,917
– – 2.18% 9
2025
Q3 		$14.9M Hold
17,653,917
– – 1.07% 8
2025
Q2 		$12.8M Hold
17,653,917
– – 4.09% 6
2025
Q1 		$15.2M Hold
17,653,917
– – 2.17% 7
2024
Q4 		$29.7M Hold
17,653,917
– – 3.98% 5
2024
Q3 		$50.3M Hold
17,653,917
– – 4.42% 7
2024
Q2 		$41.3M Hold
17,653,917
– – 3.52% 7
2024
Q1 		$51.9M Hold
17,653,917
– – 3.75% 8
2023
Q4 		$52.8M Buy
+17,653,917
New +$50.5M 3.25% 9

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

AH Capital Management's NAUT Position: Q2 2026 in Review

AH Capital Management reduced its Nautilus Biotechnolgy (NAUT) stake by 49% in Q2 2026, selling an estimated $22.7M and leaving 9,063,054 shares worth $16.9M. The position accounts for 0.12% of the portfolio, ranked #12.

AH Capital Management first reported a position in NAUT in Q4 2023 and has held it in 11 quarters since. The position peaked at $68.5M in Q1 2026. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • AH Capital Management held 9,063,054 shares of Nautilus Biotechnolgy worth $16.9M as of Q2 2026.
  • AH Capital Management sold 8,590,863 Nautilus Biotechnolgy shares in Q2 2026, an estimated $22.7M.
  • Nautilus Biotechnolgy made up 0.12% of AH Capital Management's portfolio in Q2 2026, its #12 holding.
  • AH Capital Management first reported a position in Nautilus Biotechnolgy in Q4 2023 and has held it in 11 quarters since.
  • AH Capital Management's Nautilus Biotechnolgy position peaked at $68.5M in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on AH Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.